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Background: It has been shown that upper limbs activity increases the respiratory
workload in patients with chronic respiratory failure (CRF). The object of the
present study was to investigate whether, in these patients: (i) noninvasive positive
pressure ventilation (NPPV) could sustain the inspiratory muscles to meet the
greater ventilatory demand during upper limbs activity with the arm elevation test
(AE); (ii) proportional assist ventilation (PAV) might be superior to pressure support
ventilation (PSV) during AE, because of its potential more adaptable response to
sudden changes in the ventilatory pattern.ee front matter & 2005
med.2005.10.007
ing author. Tel.: +390 35
ess: arossi@ospedaliriunMethods: The study was performed in the pulmonary function laboratory of the
Pulmonary Division in Verona General Hospital, Verona, Italy. We studied 8 male
patients with CRF due to chronic obstructive pulmonary disease (COPD). Each
patient received 2 treatment in random order with a crossover design: spontaneous
breathing (SB), SB with AE, either PSV or PAV without and with AE, SB without and
with AE, either PSV or PAV without and with AE. We measured: lung function tests,
lung mechanics, ventilatory pattern and diaphragmatic effort (pressure time
product, PTPdi).
Results: (i) AE increases minute ventilation (+14%) and PTPdi (+64%); (ii) ventilatory
support, both with PSV and PAV unloads the diaphragm both at rest (PTPdi 77% and
54%, respectively) and during arm elevation (PTPdi 54% and 44%, respectively).
Conclusions: PAV and PSV unloads the diaphragm in patients with CRF due to COPD
both during SB and AE; PAV can be more efficient than PSV in assisting the diaphragm




Noninvasive proportional assist ventilation and pressure support ventilation 973compared to PSV. Noninvasive ventilatory support should be considered in
rehabilitation programs for training of upper limbs activity.
& 2005 Elsevier Ltd. All rights reserved.Introduction
It has been reported that pulmonary rehabilitation
is an effective intervention in the management of
patients with chronic obstructive pulmonary dis-
ease (COPD).1–3 However, poor exercise tolerance
due to the mechanical abnormalities of the
respiratory system in those patients might cause
significant limitation to rehabilitation programs.4–6
Artificial ventilatory assistance could improve ex-
ercise tolerance and hence help severe COPD
patients to achieve a higher level of training.7–10
This approach has been applied during lower limbs
exercise only, whereas also upper limbs exercise
can be important for the daily activities and the
quality of life of such patients.11
Some years ago, a series of papers by Celli
and colleagues12–15 showed that, in patients
with severe COPD, simple arm elevation (AE)
for a few minutes determined a sharp and
remarkable increase in the patient’s inspiratory
effort to meet the substantial rise in the
metabolic load and ventilatory demand. More
recently, Velloso and colleagues11 showed that
many daily activities involving arm exercise deter-
mined a substantial rise in ventilatory demand. We
wondered whether noninvasive positive pressure
ventilation (NPPV) could be helpful during AE as it
was shown to be during conventional cycle ex-
ercise. If so, NPPV could help in more complete
rehabilitation programs, including upper limb
exercise.
In a few recent reports, proportional assist
ventilation (PAV) was applied16–19 while either
pressure support ventilation (PSV)7,9,10 or contin-
uous positive airway pressure (CPAP)8 was the mode
of ventilatory assistance in previous studies. The-
oretically, PAV should better adapt to a sharp rise in
ventilatory demand than PSV.20 In fact, PAV is a
patient-guided ventilatory mode in which the level
of assistance is proportional to the patient’s
ventilatory drive and timing. To our knowledge,
PAV and PSV were compared in stable COPD
patients,21,22 and during lower limb exercise,16,17
but not yet during arm exercise.
Therefore, this study was designed to answer to 2
questions. First we aimed to investigate whether
ventilatory assistance could unload the inspiratory
muscles and meet the greater ventilatory demand
during upper limb exercise in the form of the AEtest. Second we compared PAV and PSV to investi-
gate whether PAV was superior to PSV as it might be
hypothesized on the basis of theory.Methods
This protocol was approved by the Institutional
Ethics Committee of the Azienda Ospedaliera di
Verona, where the experimental procedure was
performed and informed consent was given by the
patients.Patients
We studied 8 male patients (64.9711.4 years) with
chronic respiratory failure (CRF) due to COPD. In 2
of the 8 patients also kyphoscoliosis was present.
Diagnosis of COPD was made initially according to
the European Respiratory Society Guidelines.23 The
diagnosis of CRF was based on the clinical
records showing chronic hypoxia and chronic CO2
retention, i.e. values of PaCO2 445mmHg,
consistently in the months, if not years, preceding
the study. Values of arterial blood gases at the time
of inclusion in the study are shown in Table 1. In all
patients with one exception, arterial blood was
sampled after a few minutes of breathing room air.
In one patient (no. 7) arterial blood was sampled
while breathing oxygen (2 L/min)-enriched air,
because the patient did not tolerate oxygen with-
drawn. Spirometric values from clinical records are
also reported in Table 1. In addition to the evidence
of CRF and COPD, inclusion criteria were the
followings: (i) stable clinical condition, i.e. stabi-
lity in blood gas values and pH (47.35), and lack of
exacerbations in the preceding 4 weeks; (ii)
absence of exclusion criteria. The latter were: (i)
presence of other chronic organ failure (e.g. renal,
hepatic or cardiac failure documented by certified
clinical history); (ii) any kind of neoplastic disorder;
(iii) inability to cooperate; (iv) lack of informed
consent.
All patients were on long-term oxygen therapy.
Seven patients were also on home NPPV, in the PSV
mode with bi-level ventilator for 5–6 h in the day or
night, depending on the patient’s and caring
physician’s choice. All the patients received regular
treatment with inhaled bronchodilators, inhaled
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Table 1 Patients’ characteristics, arterial blood gases and spirometry.




VC (L) FEV1 (L) FEV1/VC
1 COPD 79 7.39 61 53 2.26 0.72 0.32
2 COPD 62 7.35 41 67 0.75 0.37 0.39
3 COPD 71 7.37 51 58 1.09 0.56 0.51
4 COPD 70 7.38 54 48 2.55 0.79 0.31
5 COPD 48 7.40 52 54 2.60 0.80 0.31
6 COPD 76 7.35 52 66 2.08 0.58 0.28
7 COPD 50 7.37 81 63 1.72 0.84 0.49
8 COPD 83 7.44 51 57 2.22 1.13 0.51
Mean 65 7.38 56 59 1.91 0.72 0.40
SD 11 0.03 12 6 0.67 0.23 0.10
COPD and kyphoscoliosis.
R. Poggi et al.974steroids, and other medications, according to the
prescriptions of the caring physicians.Measurements
Routine spirometry was obtained by means of a
Collins type 13 L spirometer (Biomedin, Padova,
Italy) with the patient in the seated posture
according to standard procedure.24
Flow ð _VÞ was measured with a heated Lilly
pediatric-type pneumotachometer connected to a
differential pressure transducer (SM5552-001-D,
Silicon Microstructures Inc., Fremont, CA). The
pneumotachograph was inserted between the nasal
mask and the plateau valve of the ventilator
circuit.21
Volume (V) was obtained from numerical inte-
gration of the flow signal. Changes in pleural (Ppl)
and abdominal (Pab) pressures were estimated from
changes in oesophageal (Pes) and gastric (Pga)
pressures, respectively. Both Pes and Pga were
measured using 2 balloon-tipped catheter systems
connected to 2 differential pressure transducers
(SM5552-030-D, Silicon Microstructures Inc., Fre-
mont, CA). The catheters were 80 cm in length and
1.7mm in internal diameter; the balloons were
10 cm in length and 2.4 cm in circumference.
Another similar catheter and pressure transducer
(SM5552-030-D, Silicon Microstructures Inc., Fre-
mont, CA) were used to sample the pressure at the
airway opening (Pao) via a side port inserted
between the nasal mask and the pneumotacho-
graph. Transpulmonary (Pl) and transdiaphragmatic
(Pdi) pressures were obtained by subtracting Pes
from Pao and Pga, respectively.
22Minute ventilation ð _VEÞ; tidal volume (VT), in-
spiratory (TI) and expiratory time (TE), total cycle
duration (TT), respiratory frequency (f), mean
inspiratory flow (VT/TI), and the duty cycle (TI/
TT) were obtained as average values from 1min
continuous records of flow and volume. Transpul-
monary pressure was used to calculate dynamic
lung compliance (Cdyn,L) and pulmonary resistance
at mid-inspiratory volume (RLinsp) as previously
described.25 Dynamic intrinsic positive end-expira-
tory pressure (PEEPi,dyn) was measured as the
decrease in Ppl preceding the inspiratory flow
and, when necessary, this measurement was cor-
rected for expiratory muscles activity.25 The
magnitude of the diaphragmatic effort was esti-
mated from the pressure-time product
(PTPdi).
21,22,25Experimental procedure and study design
Patients were studied in the morning, in seated and
comfortable position. After the application of
topical anaesthesia with xylocaine spray 10%, the
2 balloon-tipped catheters were consecutively
inserted through the nose into the stomach. The
patients were encouraged to swallow during this
procedure. The balloons were then inflated with
1ml of air and a positive pressure swing synchro-
nous with manual pressure of the abdominal wall
indicated that they were in the stomach. The
oesophageal balloon was then deflated and with-
drawn into the middle third of the oesophagus and
inflated with 0.5–0.7ml of air. The ‘‘occlusion test’’
was performed to verify the correct positioning of
the oesophageal balloon, and it was satisfactory in
every instance. Then a commercial nasal mask
ARTICLE IN PRESS
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connected to the pneumotachograph and patients
were instructed to keep their mouth closed and
breathing normally. PAV and PSV were delivered by
means of the Vision ventilator (Respironics Inc.,
Murrysville, PA). The ventilator delivers PAV accord-
ing to the equation of motion generating a pressure
in proportion to patient’s spontaneous ef-
fort.21,22,26 A value of CPAP amounting to 4 cmH2O
was set by the ventilator for both PAV and PSV.
Once the patient was accustomed to the experi-
mental setting and appeared to be relaxed, the
procedure to set PAV, namely volume assist (VA) and
flow assist (FA) adjustments, as well as PSV were
performed as previously described.21,22 Oxygen
administration was continuously delivered through-
out the procedure to guarantee a SpO2492%, as
measured with finger pulsoximetry. The patients
breathed through the nose mask and the pneumo-
tachograph, having removed the ventilator tubing
for about 5min (spontaneous breathing ¼ SB). Then
the patient, still seated, was asked to raise both
arms anteriorly at a 901 angle and to maintain the
posture for 2min (unsupported arm elevation
(AE) ¼ SB–AE). Thereafter we randomized the
administration of PAV or PSV. The patient received
ventilatory assistance (PAV or PSV) for 5min at rest,
then a 2min AE test was repeated and recorded
during PAV or PSV (PAV–AE and PSV–AE, respec-
tively). Then the procedure was repeated for the
other mode of ventilatory assistance. Each patientFigure 1 Representative record form patient #4 during both
elevated test performed breathing spontaneous (SB–AE) and
(PSV–AE).followed the entire procedure for a total length of
about 40min, according to the randomized se-
quence.Data analysis
Using a Pentium II 266MHz personal computer
equipped with an A/D board (DI 200, DATAQ
Instruments, Akron OH), all signals were analogue
to digital converted, displayed on line throughout
the procedure, and stored on hard disk at a
sampling rate of 100 Hz. Data were collected under
each experimental condition. The mean value of
each physiologic variable during the last minute of
recording was used for subsequent analysis.
Results are expressed as mean71standard devia-
tion (SD). One-way analysis of variance for repeated
measures (ANOVA) was performed, and, when
allowed by the F value, the significance between
treatments was computed using Fisher’s protected
least significant difference test. Probability
values less than 0.05 (Po0:05) were considered
significant.Results
A representative record from a patient through
different phases of the study is shown in Fig. 1.
Table 2 shows mean (7SD) data for the breathingspontaneous breathing at rest (SB) and during the arm
under ventilatory assistance with PAV (PAV–AE) and PSV
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Table 2 Breathing pattern and respiratory mechanics in the different conditions of the study.
SB SB–AE PAV PAV–AE PSV PSV–AE
VT (L) 0.4270.08 0.4670.15 0.5370.11 0.7270.4
 0.6270.2 0.7770.4
F (b/min) 2275 2577 2176 2278 1874 2076
V0E (L/min) 7.971.4 9.071.9 9.672.2 13.671.9 9.771.1 11.973.2
TI (s) 1.270.5 1.170.6 1.170.3 1.270.7 1.270.4 1.270.6
TE (s) 1.770.4 1.670.5 2.0370.6 1.970.8 2.370.5 2.170.7
TI/TTOT 0.4170.05 0.4170.05 0.3570.04 0.3870.03 0.3470.03 0.3670.06
Cdyn,L (L cmH2O
1) 0.0870.05 0.0770.05 0.1270.07 0.1170.07 0.1270.07 0.1170.07
RLinsp (cmH2O L
1 s) 11.873.8 13.874.6 9.172.9 10.774.0 10.073.2 10.974.1
PEEPi,dyn (cmH2O) 2.271.4 5.774.9
 1.370.9 3.674.4 0.971.0 3.874.3
PTPdi (cmH2Omin) 2927130 4787277
 134774 2687170 68727 219775
DPTPdi (cmH2Omin) — 1867220 — 1337166 — 1517168
DV0E (L/min) — 1.1171.34 — 3.9671.69 — 2.3272.15,y
Definition of abbreviations: SB, spontaneous breathing; AE, arm elevation; PAV, proportional assist ventilation; PSV, pressure
support ventilation; VT, tidal volume; f, frequency of breathing; VE, minute ventilation; TI, inspiratory time; TE, expiratory
time; TTOT, total breathing duration; Cdyn,L, dynamic lung compliance; RL, total pulmonary resistance; PEEPi,dyn, dynamic
intrinsic positive end expiratory pressure; PTPdi, pressure time product of diaphragm; DPTPdi, PTPdi difference between each
treatment and corresponding AE; DV0E, V0E difference between each treatment and corresponding AE.
Po0:05 vs. SB.
yPo0:05 vs. PAV–AE.
R. Poggi et al.976pattern and respiratory mechanics. We failed to
observe any difference in the reaction to ventila-
tory support between the 2 patients who had COPD
and kyphoskoliosis and the 6 patients with only
COPD. Since the 2 baseline measurements preced-
ing PAV and PSV were not different, we refer to the
first baseline SB and the first AE test. On average,
AE caused slight changes in the breathing pattern
and minor changes in dynamic compliance (12%
on average) and pulmonary resistance (+17% on
average). By contrast, PEEPi,dyn more than doubled
(+160% on average) and was associated with a
remarkable increase in PTPdi (+64%, on average). In
2 of the 8 patients, _VE not only did not increase but
rather decreased from SB to SB–AE.
In comparison with baseline SB, both PAV and PSV
increased minute ventilation (+22% and +23% on
average, respectively). In particular, PSV increased
VT (+48% on average) and reduced the frequency of
breathing (18%, on average). PEEPi substantially
decreased during PAV and PSV periods (41% and
59% on average, respectively), and lung compli-
ance increased (+50% on average). Both PAVand PSV
reduced significantly the diaphragmatic effort
compared to unsupported breathing (PTPdi: 54%
and 77%, on average, respectively) (Table 2).
When the AE exercise was performed during
ventilatory assistance, _VE and VTwere substantially
greater (50% on average) and the inspiratory effort
lower than during unsupported AE. On average,
PTPdi decreased to 44% with PAV and to 54%,
with PSV. PEEPi,dyn decreased by more than 30%
with both modes of ventilatory assistance incomparison with the unsupported AE conditions.
In other words, ventilatory assistance during AE
allowed a higher ventilation with lower inspiratory
effort. During PAV–AE all patients were able to
increase _VE.
To ascertain the efficiency of the patient–venti-
lator system, we computed the increase in the
magnitude of the inspiratory effort (DPTPdi, re-
quired to meet the increase in ventilation ðD _VEÞ
from rest (SB, PAV, and PSV) to unsupported (SB–AE)
and supported (PAV–AE and PSV–AE) arm elevation.
The increase of the diaphragmatic effort needed to
sustain ventilation during AE was not significantly
different between the unsupported (SB) and the
assisted condition (PAV and PSV). In other words,
though starting from very different baseline values,
the increase in respiratory effort was very similar
when arms were elevated. Clearly, the final
diaphragmatic effort remained lower with ventila-
tory assistance than during unsupported breathing,
because of the different starting values. On the
other hand, the rise in ventilation was greater with
both modes of ventilatory assistance than without
any support (SB). In other words, a similar
increase in the inspiratory effort generated more
ventilation when the patients were connected to
the ventilator than when they were breathing on
their own. However, the rise in _VE with PAV was
significantly greater not only compared to SB, but
also compared to PSV. This is illustrated in Fig. 2
where the output, i.e. _VE is plotted against the
input from the diaphragm, i.e. PTPdi. It can be
observed that the steeper _VE vs. PTPdi relationship
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Figure 2 Relationship between changes in diaphragm
energy expenditure (PTPdi) and minute ventilation (VE)
at baseline (B) and in the last minute of arm elevation
(AE) in the 3 conditions tested: SB, spontaneous breath-
ing; PAV, proportional assist ventilation; PSV, pressure
support ventilation. Data are expressed as mean va-
lue7standard error; Po0:001 PAV vs. SB.
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patient–ventilator system was more efficient with
PAV, because a similar increase in PTP generated a
greater rise in V0E.Discussion
The results of this study show that, in patients with
stable severe COPD and CRF; (1) respiratory muscle
function is impaired during upper limb exercise;
(2) ventilatory assistance operated by both PAV and
PSV substantially unloads the diaphragm both at
rest and during AE; (3) PAV can be more efficient
than PSV in assisting the diaphragm to sustain a
greater level of V0E.
To our knowledge this is the first study addressing
mechanical ventilatory assistance, and comparing
PAV and PSV, during upper limb efforts in patients
with severe COPD and CRF. Furthermore, this study
confirms and extends the results of previous
studies, in which it was shown that artificial
ventilation can assist the respiratory muscles
during lower limb exercise and, hence, it can be
useful in rehabilitation and training programs for
COPD patients.15–17 However, our study is on a small
group of patients and the data should be considered
physiologic, preliminary data, requiring additional
confirmation in larger clinical studies.
Leg fatigue is a common limiting factor in
exercise in COPD patients.27,28 To what extent this
is due to general deconditioning of the patients or
to the systemic effects of COPD remains to beestablished. Nevertheless, training of leg skeletal
muscles can improve patient’s mobility and hence
his/her general health status and social relation-
ships. However, also the capability to use properly
the upper limbs is important in daily life activities,
e.g. washing, combing, etc.11
Upper limb exercise may impair ventilation. In
fact, the use of upper limbs may need the
activation of the accessory respiratory muscles for
the posture of the trunk.12 Under those circum-
stances, the ventilatory workload must be faced by
the diaphragm, whose pressure-generating capa-
city is impaired substantially by pulmonary hyper-
inflation.14 This condition can influence not only
daily activities but also rehabilitation programs
aimed to a more general skeletal muscle training
than only to leg exercise.
Our data are in line with the previous re-
sults.11–15 As suggested by Celli and colleagues,12,13
it was the diaphragm which had to carry over the
additional ventilatory burden during AE.
NPPV unloads the inspiratory muscles, reduces
breathlessness, and allows a better limb exercise
by a redistribution of blood flow from the respira-
tory to skeletal muscles.16,18 Similarly to PSV, PAV
unloads the inspiratory muscles of patients with
moderate to severe COPD at rest21,22 and improves
exercise tolerance and breathlessness during cycle
exercise.17,29 Bianchi and colleagues17 after their
short-term study and Hawkins and colleagues18
after their 6 weeks randomized, prospective study
concluded that ventilatory assistance in general,
and PAV in particular, could be useful in pulmonary
rehabilitation programs because of the better
exercise performance of severe COPD patients
when the respiratory muscles are unloaded and
ventilation assisted.
In the present study both PAV and PSV were able
to unload the respiratory muscles during quiet
breathing. During the AE with ventilatory assis-
tance, the additional PTPdi needed to perform the
test was slightly but not significantly lower than
without ventilatory support. However, since the
initial PTPdi with both PSV and PAV was much lower
than during SB, the additional effort was well
tolerated by all patients who could perform the AE
test without excessive dyspnea and without active
coaching.
Assisted breathing with PSV and PAV also induced
changes in minute ventilation compared to unsup-
ported breathing. It has to be noted that the rise in
_VE to match the higher ventilatory demand showed
a trend to increase with PSV (+23% on average) and
it was significantly greater with PAV (+42% on
average) than without ventilatory assistance (SB,
+14% on average). In other words, thank to the
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increased ventilatory requirements determined by
AE. However, this change reached statistical
significance only during PAV. The better efficiency
obtained with PAV, i.e. a greater rise in ventilation
for the same increase in diaphragmatic effort, can
be explained by the unique design of PAV based on
physiological considerations.20 However, the num-
ber of subjects examined in his protocol is rather
small, only 8 patients, and not completely homo-
geneous, 2 patients had also kyphoskoliosis and not
pure COPD. Under these circumstances, a type b2
error might be induced. Certainly, this is a
significant limitation of our study. In order to be
extrapolated to a more general population of
patients with CRF due to COPD, the results of this
protocol should be validated on a larger group of
patients. However, these are delicate patients, in
whom the insertion of 2 balloons, in the oesophagus
and in the stomach, to keep inside for almost 1 h, is
unpleasant and might prevent the possibility to
recruit a larger group as it may occur when using
noninvasive techniques.26 This may be considered a
preliminary physiologic study, which might be
followed by protocol on larger groups using mainly
noninvasive techniques.
In this study, 4 cmH2O of positive expiratory
pressure were set by the ventilator during both
PAV and PSV. Nava and colleagues30, and O’Dono-
ghue and colleagues31 reported that a few cmH2O
of CPAP were helpful to further reduce the
inspiratory effort during PSV in stable COPD
patients. Furthermore, Petrof and colleagues8
showed that CPAP improved the exercise capacity
of COPD patients by counterbalancing the intrinsic
PEEP. Therefore, it is very likely that positive
expiratory pressure contributed to the reduction
of patients’ inspiratory efforts. In fact, Dolmage
and Goldstein16 suggested that the combination of
CPAP and PAV increased exercise tolerance in
patients with COPD better than either alone. In
our study, the level of positive expiratory pressure
was the same with both PAV and PSV and was not
changed from rest to AE.
As recurrently cited in many experimental
procedures with PAV, a major problem is the setting
of the ventilator.16,17,19,21,24,26 According to the
theory, the tailoring of PAV would require the
measurement of the mechanical properties of the
respiratory system to implement patient’s ela-
stance and resistance in the equation of motion.20
We measured lung compliance and flow resistance
by means of the oesophageal balloon technique
only off-line at the end of the procedure (Table 2).
We did not attempt to set the ventilator according
to those data because respiratory mechanicscomputation takes time and can unduly prolong
the period during which the patients have to keep
the oesophageal balloon on, thus providing an
additional source of discomfort that can challenge
the patient’s cooperation. Hence, we decided to
set PAV at patient’s comfort,21,22 in consideration of
the cooperation required by the following proce-
dure. Nevertheless, this sort of empirical setting
did not disrupt the effectiveness of PAV and, to
some extent, made the condition more comparable
with PSV.
In conclusion, the results of the present study,
although in a small number of patients, confirm that
in patients with COPD and CRF, the use of upper limbs
poses a substantial burden on the inspiratory muscles
and in particular on the diaphragm, the contribution
of the extra-diaphragmatic respiratory muscles being
limited by their participation to the trunk posture.
We show that ventilatory assistance helps to unload
the inspiratory muscles, particularly the diaphragm,
and to match the increased ventilatory demand.
Therefore, ventilatory assistance could be considered
not only during leg exercise, but also in complete
rehabilitation programs aimed to improve the upper
limbs capability to meet the daily activities. Finally,
our data suggest that PAV can equally unload the
inspiratory muscles but follow better the changes in
ventilatory demand compared to PSV. Hence PAV, as
suggested by a few authors,16,17,29 could be consid-
ered in general rehabilitation programs for patients
with advanced COPD.References
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